HIV prevention news: Europe

NAM is launching a new monthly bulletin that covers HIV prevention news and research in Europe, and of relevance to Europe.

Our new email bulletin aims to strengthen your knowledge of the new prevention options and bring you the latest HIV prevention news and research.

Community organisations, HIV advocates, clinicians and counsellors across Europe work with people living with HIV and people at risk of HIV infection. These practitioners have a key role to play in supporting people at risk of acquiring HIV, or transmitting HIV, to understand their options and the implications of new research.

HIV prevention has been evolving rapidly in recent years, with landmark research developments in new prevention technologies and approaches, including HIV treatment as prevention, pre-exposure prophylaxis, expanded testing programmes and advocacy for proven approaches that remain unprovided, such as syringe and needle exchange and condoms in prisons.

As well as research from Europe, we’ll cover international studies that are relevant for people working on HIV prevention.

Each monthly issue will include:

  • Short summaries of the most important developments
  • Links to more detailed news stories and research reports
  • Links to background material
  • A selection of news stories from other high-quality sources.

We are initially offering the bulletin in English, Spanish, Portuguese, French and Russian.

You can sign up to receive this new monthly bulletin on the right-hand side of this page.

Subscribe today

This project has been supported via a grant from Gilead Sciences Europe Ltd, Merck & Co., Inc. and ViiV Healthcare.

Gilead Sciences Europe Ltd, Merck & Co., Inc. and ViiV Healthcare have provided funding for this project and have had no editorial control over the content of the materials.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.